90 filings
8-K
AMLX
Amylyx Pharmaceuticals Inc
10 Apr 24
Other Events
9:19am
8-K
AMLX
Amylyx Pharmaceuticals Inc
4 Apr 24
Cost Associated with Exit or Disposal Activities
7:10am
8-K
AMLX
Amylyx Pharmaceuticals Inc
14 Mar 24
Departure of Directors or Certain Officers
9:18am
8-K
AMLX
Amylyx Pharmaceuticals Inc
8 Mar 24
Amylyx Pharmaceuticals Announces Topline Results From Global Phase 3 PHOENIX
7:10am
S-8
AMLX
Amylyx Pharmaceuticals Inc
22 Feb 24
Registration of securities for employees
4:29pm
8-K
5g04cx d15smdo
22 Feb 24
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
7:08am
UPLOAD
a87s peuwb58d
20 Dec 23
Letter from SEC
12:00am
CORRESP
hq95xrj3ou0moi
19 Dec 23
Correspondence with SEC
12:00am
8-K
kb8364
7 Dec 23
Regulation FD Disclosure
7:00am
UPLOAD
ikjs69ptveqo3widf47
5 Dec 23
Letter from SEC
12:00am
8-K
nc242 ggmhjb
9 Nov 23
Amylyx Pharmaceuticals Reports Third Quarter 2023 Financial Results
6:58am
8-K
xb8n utgnwk
13 Oct 23
Other Events
5:20pm
S-8
gxixnxvd00qd18 goga
10 Aug 23
Registration of securities for employees
4:39pm
8-K
2xjxqgjawys897
10 Aug 23
Amylyx Pharmaceuticals Reports Second Quarter 2023 Financial Results
4:00pm
8-K
miec0kahztkdw3d
26 Jul 23
Other Events
4:36pm
8-K
ha9oa20h8v0m08tbza8q
23 Jun 23
Amylyx Pharmaceuticals Receives CHMP Negative Opinion on its Conditional Marketing Authorisation
5:16pm
8-K
lzi8ucr
9 Jun 23
Submission of Matters to a Vote of Security Holders
8:14am